Ipamorelin, and why it rarely appears alone.
Usually positioned as part of a stack rather than a standalone offering, which changes how you package and price it.
What it is
Ipamorelin is a synthetic pentapeptide in the growth hormone secretagogue category. It is a compounded preparation, dispensed against a prescription, and is not an approved drug product.
Packaged, not sold alone
Operationally, the notable thing about ipamorelin is that clinics rarely put it on a menu as a standalone line. It typically appears inside a combined offering, which has real consequences for how you price and package: the unit a patient buys is a program, not a vial.
That is generally good for clinic economics, because packaged offerings retain better than single purchases. It also means the pricing model has to be built around the package, not derived from compound cost plus a margin.
Which pharmacy path applies
Usually 503(a) patient-specific. Combined preparations add a wrinkle: what a given pharmacy will and will not prepare together varies, and that constrains which packages you can actually offer. Confirm before the menu is published, not after a patient has bought.
Menu fit
Sits with the rest of the secretagogue category and fits practices already running that conversation. Because it is usually packaged, it tends to enter a menu in the second wave rather than the first, once the clinic has seen which categories its patients actually choose.
This library is written for clinic operators making menu, sourcing and inventory decisions. It is not medical advice, contains no dosing or protocol guidance, and makes no claim about the safety or effectiveness of any compounded preparation. Compounded medications are not FDA-approved. What any individual patient should receive is a decision for a licensed practitioner.
Ipamorelin questions.
Can it be combined with other compounds in one preparation?
Should it be on a starter menu?
Your patients are already asking about peptides.Make sure your clinic is ready to answer.
Build and launch your peptide program with Revival RX Partners in 90 days.
Important
- Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
- All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
- Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
- Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.